Clear cell sarcoma of kidney
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
This and the YWHAE-NUTM2B/E fusion, the second most common recurrent molecular alteration in CCSK (10%), are considered to be mutually exclusive.
|
28440018 |
2017 |
Clear cell sarcoma of kidney
|
0.340 |
Biomarker
|
disease |
BEFREE |
BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney.
|
26493387 |
2016 |
Clear cell sarcoma of kidney
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Until now, the sole recurrent genetic aberration identified in CCSKs is t(10;17)(q22;p13), which gives rise to a fusion transcript of YWHAE and NUTM2B/E.
|
26542179 |
2016 |
Clear cell sarcoma of kidney
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
Based on the chromosome 10 breakpoint identified by FISH and the sequences of the full-length transcripts obtained, the FAM22 members involved in the translocation in these CCSK cases include FAM22B and FAM22E.
|
22294382 |
2012 |
Clear cell sarcoma of kidney
|
0.340 |
FusionGene
|
disease |
ORPHANET |
Based on the chromosome 10 breakpoint identified by FISH and the sequences of the full-length transcripts obtained, the FAM22 members involved in the translocation in these CCSK cases include FAM22B and FAM22E.
|
22294382 |
2012 |
Endometrial Stromal Sarcoma
|
0.320 |
Biomarker
|
disease |
BEFREE |
Collectively, these findings suggest that abnormality in the loci of YWHAE, FAM22A and FAM22B, which are known to be associated with oncogenesis of endometrial stromal sarcoma, may contribute to the development of uterine angiosarcoma.
|
24125656 |
2014 |
Endometrial Stromal Sarcoma
|
0.320 |
FusionGene
|
disease |
ORPHANET |
Endometrial stromal tumors: the new WHO classification.
|
25299308 |
2014 |
Endometrial Stromal Sarcoma
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
A subset of endometrial stromal sarcoma harbors t(10;17)(q23;p13), which results in the genetic fusion between YWHAE and 1 of 2 highly homologous FAM22 family members-FAM22A or FAM22B.
|
23159154 |
2013 |
Endometrial Stromal Sarcoma
|
0.320 |
FusionGene
|
disease |
ORPHANET |
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
|
22223660 |
2012 |
Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
However, insufficient frequency of YWHAE, NUTM2A, and NUTM2B gene rearrangement and absence of mutation in both the c-kit and PDGFRA genes suggested that this tumor should be categorized as epithelioid leiomyosarcoma.
|
28288693 |
2017 |
Uterine Angiosarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Although it was reported previously that there was breakage in YWHAE, NUTM2A (FAM22A), and NUTM2B (FAM22B) in a case of uterine angiosarcoma, no breakage in these loci was detected by fluorescence in situ hybridization in the present case.
|
26352549 |
2016 |
Neoplasms
|
0.020 |
GeneticVariation
|
group |
BEFREE |
One tumor with t(10;17)(q22;p13) involving fusion of YHWAE with NUTM2B was identified.
|
26158413 |
2015 |
Uterine Angiosarcoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Breakages at YWHAE, FAM22A, and FAM22B loci in uterine angiosarcoma: a case report with immunohistochemical and genetic analysis.
|
24125656 |
2014 |
Leiomyosarcoma, Epithelioid
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
However, insufficient frequency of YWHAE, NUTM2A, and NUTM2B gene rearrangement and absence of mutation in both the c-kit and PDGFRA genes suggested that this tumor should be categorized as epithelioid leiomyosarcoma.
|
28288693 |
2017 |
Undifferentiated round cell sarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
An identical YWHAE-NUTM2B fusion was found in another URCS case of a 5-month-old girl with a back lesion.
|
26945340 |
2016 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Collectively, these findings suggest that abnormality in the loci of YWHAE, FAM22A and FAM22B, which are known to be associated with oncogenesis of endometrial stromal sarcoma, may contribute to the development of uterine angiosarcoma.
|
24125656 |
2014 |